Compounds are provided which are glucokinase activators and thus are useful in treating diabetes and related diseases and have the structure wherein in the ring represents one or two double bonds； R1 is alkyl, aryl, arylalkyl, heteroaryl, or heteroarylalkyl； R2 is alkyl, aryl, arylalkyl, heteroaryl, or heteroarylalkyl； R5 is as defined herein； Z is O, S, S(O), S(O)2, or NR5a； X is S, O, N, NR3, or CR3； Y is NCR4 or NR4； R3, R4, and R5 are as defined herein； R8 is aryl, heteroaryl, —PO(OR9)(OR10), —PO(OR9)R10 or —P(O)(R9)R10 (wherein R9 and R10 are as defined herein)/R6 and R7 are independently H, halogen, or alkyl； m is 0 or 1； and n is 0 to 3, or a pharmaceutically acceptable salt thereof. A method for treating diabetes and related diseases employing the above compounds is also provided.
